These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7317899)

  • 21. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X.
    Montorsi P; Cozzi S; Loaldi A; Fabbiocchi F; Polese A; De Cesare N; Guazzi MD
    Am J Cardiol; 1990 Aug; 66(3):302-7. PubMed ID: 2368675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
    Rettig GF; Jakob M; Koch HP
    Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coronary vasomotor equivalents in the electrocardiographic behavior in induced ischemia].
    Fabbiocchi F; Ravagnani P; Montorsi P; Loaldi A; De Cesare N; Polese A; Guazzi MD
    Cardiologia; 1990 Sep; 35(9):713-9. PubMed ID: 2091823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris.
    Hiroki T; Inoue T; Yoshida T; Arakawa K
    Arzneimittelforschung; 1982; 32(12):1572-4. PubMed ID: 6891598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nifedipine on exercise tolerance in angina pectoris.
    McIlwraith GR; Kidner PH; Oram S
    Br Heart J; 1980 Sep; 44(3):335-41. PubMed ID: 7426191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris.
    Martsevich SY; Koutishenko N; Metelitsa VI
    Int J Cardiol; 1993 Dec; 42(3):298-301. PubMed ID: 8138342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximal exercise testing in patients with spontaneous angina pectoris associated with transiet ST segment elevation. Risks and electrocardiographic findings.
    Detry JM; Mengeot P; Rousseau MF; Cosyns J; Ponlot R; Brasseur LA
    Br Heart J; 1975 Sep; 37(9):897-903. PubMed ID: 1103910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise-induced intermittent angina and ST-segment depression.
    Scardi S; Pivotti F; Pandullo C; Fonda F
    Am J Cardiol; 1985 May; 55(11):1427-8. PubMed ID: 3993584
    [No Abstract]   [Full Text] [Related]  

  • 30. Electrocardiographic evidence for a cardioprotective effect of nifedipine during experimental hypercalcemia.
    Schäfer W; Schäfer A; Schäfer H
    Basic Res Cardiol; 1982; 77(1):12-25. PubMed ID: 7073650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of the ST-T pattern in the exercise electrocardiogram.
    Fukushima M
    Jpn Circ J; 1977 Nov; 41(11):1209-19. PubMed ID: 592473
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrocardiographic exercise test in subjects not suffering from angina].
    MUSSAFIA A; BOLDRINI R; BOCCARDELLI V
    Prog Med (Napoli); 1953 Mar; 9(5):133-6. PubMed ID: 13074265
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperglycaemic effect of nifedipine.
    Greenwood RH
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):50. PubMed ID: 6797640
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of electrocardiographic changes during exercise (modified double two-step test).
    YU PN; SOFFER A
    Circulation; 1952 Aug; 6(2):183-92. PubMed ID: 14936213
    [No Abstract]   [Full Text] [Related]  

  • 35. Nifedipine.
    Rudd P
    West J Med; 1988 Jul; 149(1):57. PubMed ID: 18750436
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart medications: indications and interactions in stress testing.
    Duncan BH; Sillaman LE
    J Nucl Cardiol; 1999; 6(3):357-61. PubMed ID: 10385191
    [No Abstract]   [Full Text] [Related]  

  • 37. The dose-response effects of nifedipine of ST-segment changes in exercise testing: preliminary studies.
    Fox KM; Deanfield J; Jonathan A; Selwyn A
    Cardiology; 1981; 68 Suppl 2():209-12. PubMed ID: 7317899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of angina pectoris with nifedipine: importance of dose titration.
    Deanfield J; Wright C; Fox K
    Br Med J (Clin Res Ed); 1983 May; 286(6376):1467-70. PubMed ID: 6405844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal effect of nifedipine after intracoronary and intravenous administration judged by reduction of ischemic ST-segment depression in exercise tests.
    Schulz W; Kaltenbach M
    Cardiology; 1981; 68 Suppl 2():200-8. PubMed ID: 7317898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of propranolol and nifedipine in the medical management of angina pectoris.
    Fox KM; Jonathan A; Selwyn AP
    Clin Cardiol; 1981 May; 4(3):125-9. PubMed ID: 7261486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.